The dosages are 3ug, 10ug then 30ug for the final cohort.
The final dosage for cohort 1 was on 14 August so we are now (as of Monday) 4 weeks post that event. I guess the Safety Review is no doubt underway as we speak. I don't know what is involved and how long it takes - maybe someone can assist with that knowledge. But, hopefully a short process and cohort 2 can commence within a week or two. No doubt we will be updated on 27 Sept at the conference call. But I'm very keen to hear some feedback on the discussions with big/other pharma re deals, mergers, licenses, buyouts etc. This is what will move the share price.
The dosages are 3ug, 10ug then 30ug for the final cohort.The...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.005(5.26%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $126.7K | 1.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10306 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 91480 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.9¢ |
Change
0.005 ( 4.21 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.7¢ | 96942 | ||
| Last updated 15.25pm 14/05/2024 ? | |||||
| PYC (ASX) Chart |